메뉴 건너뛰기




Volumn 16, Issue 3, 2013, Pages 329-337

Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: Serum trefoil factor 3 is a stable biomarker

Author keywords

Cancer biomarker; Gastric ulcer; Helicobacter pylori; Pepsinogen test; Trefoil factor

Indexed keywords

AMOXICILLIN; BACTERIUM ANTIBODY; CLARITHROMYCIN; HELICOBACTER PYLORI ANTIBODY; LANSOPRAZOLE; OMEPRAZOLE; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II; RABEPRAZOLE; TREFOIL FACTOR 1; TREFOIL FACTOR 2; TREFOIL FACTOR 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

EID: 84880796014     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0185-y     Document Type: Article
Times cited : (26)

References (14)
  • 1
    • 0041837509 scopus 로고    scopus 로고
    • Trefoil factors: Initiators of mucosal healing
    • 14506475 10.1038/nrm1203 1:CAS:528:DC%2BD3sXnsVKqsLY%3D
    • Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003;4:721-32.
    • (2003) Nat Rev Mol Cell Biol , vol.4 , pp. 721-732
    • Taupin, D.1    Podolsky, D.K.2
  • 2
    • 78649706953 scopus 로고    scopus 로고
    • Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans
    • 20801119 10.1053/j.gastro.2010.08.043 1:CAS:528:DC%2BC3cXhsFakt77O
    • Peterson AJ, Menheniott TR, O'Connor L, Walduck AK, Fox JG, Kawakami K, et al. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans. Gastroenterology. 2010;139:2005-17.
    • (2010) Gastroenterology , vol.139 , pp. 2005-2017
    • Peterson, A.J.1    Menheniott, T.R.2    O'Connor, L.3    Walduck, A.K.4    Fox, J.G.5    Kawakami, K.6
  • 3
    • 25144472593 scopus 로고    scopus 로고
    • Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis
    • 16166422 10.1158/1078-0432.CCR-05-0671 1:CAS:528:DC%2BD2MXhtVShsb7P
    • Dhar DK, Wang TC, Tabara H, Tonomoto Y, Maruyama R, Tachibana M, et al. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis. Clin Cancer Res. 2005;11:6472-8.
    • (2005) Clin Cancer Res , vol.11 , pp. 6472-6478
    • Dhar, D.K.1    Wang, T.C.2    Tabara, H.3    Tonomoto, Y.4    Maruyama, R.5    Tachibana, M.6
  • 5
    • 79960284255 scopus 로고    scopus 로고
    • The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer -A new marker for gastric cancer risk
    • 21455714 10.1007/s00535-011-0396-8 1:CAS:528:DC%2BC3MXns12mtLg%3D
    • Kaise M, Miwa J, Tashiro J, Ohmoto Y, Morimoto S, Kato M, et al. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer -a new marker for gastric cancer risk. J Gastroenterol. 2011;46:736-45.
    • (2011) J Gastroenterol , vol.46 , pp. 736-745
    • Kaise, M.1    Miwa, J.2    Tashiro, J.3    Ohmoto, Y.4    Morimoto, S.5    Kato, M.6
  • 6
    • 0029130503 scopus 로고
    • The clinical application of the serum pepsinogen i and II levels as a mass screening method for gastric cancer
    • 8540312 10.1007/978-1-4615-1871-6-17 1:CAS:528:DyaK2MXptlKhu7k%3D
    • Miki K, Ichinose M, Kakei N, Yahagi N, Matsushima M, Tsukada S, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. Adv Exp Med Biol. 1995;362:139-43.
    • (1995) Adv Exp Med Biol , vol.362 , pp. 139-143
    • Miki, K.1    Ichinose, M.2    Kakei, N.3    Yahagi, N.4    Matsushima, M.5    Tsukada, S.6
  • 7
    • 0033042057 scopus 로고    scopus 로고
    • Accuracy of screening for gastric cancer using serum pepsinogen concentrations
    • 10205207 10.1136/gut.44.5.693 1:STN:280:DyaK1M3itFKrug%3D%3D
    • Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut. 1999;44:693-7.
    • (1999) Gut , vol.44 , pp. 693-697
    • Kitahara, F.1    Kobayashi, K.2    Sato, T.3    Kojima, Y.4    Araki, T.5    Fujino, M.A.6
  • 8
    • 4644297746 scopus 로고    scopus 로고
    • Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening
    • 15333273 10.1258/0969141041732184 1:STN:280:DC%2BD2cvivVCqtg%3D%3D
    • Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen. 2004;11:141-7.
    • (2004) J Med Screen , vol.11 , pp. 141-147
    • Dinis-Ribeiro, M.1    Yamaki, G.2    Miki, K.3    Costa-Pereira, A.4    Matsukawa, M.5    Kurihara, M.6
  • 9
    • 80052107345 scopus 로고    scopus 로고
    • Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening
    • Aikou S, Ohmoto Y, Gunji T, Matsuhashi N, Ohtsu H, Miura H, et al. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology. 2011;141:837-45
    • (2011) Gastroenterology , vol.141 , pp. 837-845
    • Aikou, S.1    Ohmoto, Y.2    Gunji, T.3    Matsuhashi, N.4    Ohtsu, H.5    Miura, H.6
  • 10
    • 50249175156 scopus 로고    scopus 로고
    • Trefoil factor 3: A novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
    • 18682706 10.1038/sj.bjc.6604546 1:CAS:528:DC%2BD1cXhtVGgtLfE
    • Bignotti E, Ravaggi A, Tassi RA, Calza S, Rossi E, Falchetti M, et al. Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas. Br J Cancer. 2008;99:768-73.
    • (2008) Br J Cancer , vol.99 , pp. 768-773
    • Bignotti, E.1    Ravaggi, A.2    Tassi, R.A.3    Calza, S.4    Rossi, E.5    Falchetti, M.6
  • 11
    • 32944478752 scopus 로고    scopus 로고
    • Plasma levels of trefoil factors are increased in patients with advanced prostate cancer
    • 16467092 10.1158/1078-0432.CCR-05-1545 1:CAS:528:DC%2BD28XhtFeiur0%3D
    • Vestergaard EM, Borre M, Poulsen SS, Nexø E, Tørring N. Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. Clin Cancer Res. 2006;12:807-12.
    • (2006) Clin Cancer Res , vol.12 , pp. 807-812
    • Vestergaard, E.M.1    Borre, M.2    Poulsen, S.S.3    Nexø, E.4    Tørring, N.5
  • 12
    • 33847338890 scopus 로고    scopus 로고
    • Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan
    • 17323193 10.1007/s10787-006-0009-y 1:STN:280:DC%2BD2s7it1Okuw%3D%3D
    • Kawai T, Miki K, Ichinose M, et al. Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan. Inflammopharmacology. 2007;15:31-5.
    • (2007) Inflammopharmacology , vol.15 , pp. 31-35
    • Kawai, T.1    Miki, K.2    Ichinose, M.3
  • 13
    • 0036057809 scopus 로고    scopus 로고
    • Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues
    • 12210076 10.1002/path.1147 1:CAS:528:DC%2BD38Xntlekurs%3D
    • Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, et al. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol. 2002;197:582-8.
    • (2002) J Pathol , vol.197 , pp. 582-588
    • Leung, W.K.1    Yu, J.2    Chan, F.K.3    To, K.F.4    Chan, M.W.5    Ebert, M.P.6
  • 14
    • 34247637616 scopus 로고    scopus 로고
    • Tissue localization of human trefoil factors 1, 2 and 3
    • 17242463 10.1369/jhc.6A7100.2007 1:CAS:528:DC%2BD2sXkvVyqsLY%3D
    • Madsen J, Nielsen O, Tornoe I, Thim L, Holmskov U. Tissue localization of human trefoil factors 1, 2 and 3. J Histochem Cytochem. 2007;55:505-13.
    • (2007) J Histochem Cytochem , vol.55 , pp. 505-513
    • Madsen, J.1    Nielsen, O.2    Tornoe, I.3    Thim, L.4    Holmskov, U.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.